Brain Gene Patterns Reveal Shared and Unique Paths in Parkinson‑Like Diseases

A new study examined the gene activity in nearly a thousand brain samples from people who had died with Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, Alzheimer’s disease or no brain disease. The researchers used a large database of post‑mortem tissue from the front part of the brain, which is often damaged in these disorders. They carefully adjusted for age, sex, RNA quality, the lab that handled each sample and how many neurons versus glial cells were present. All of the conditions showed a drop in neuron‑specific genes and an increase in glial markers, pointing to loss of neurons as a common theme. However, the study also found that each disease had its own distinct pattern of which genes were turned down or up. The biggest common thread was a reduction in pathways that keep proteins folded, produce energy in mitochondria, manage RNA and repair DNA. These processes seem to be the core of neurodegeneration.When the researchers grouped the diseases, they saw that Parkinson’s disease and dementia with Lewy bodies cluster together, as do progressive supranuclear palsy and corticobasal degeneration. Multiple system atrophy sits in between, which may reflect its glial‑cell involvement. This clustering suggests that two main families of brain disorders exist: one driven by alpha‑synuclein protein build‑up and the other by tau protein abnormalities. The team has made all of their data available through an interactive website. Scientists can look up any gene or pathway, compare how it behaves in different diseases and generate new ideas for treatment. This resource is the most extensive map yet of how genes act in Parkinson‑like disorders and offers a clear picture of both shared and unique mechanisms. The findings help explain why some drugs that work for one Parkinson‑like disease may not help another. They also highlight key cellular processes that could be targeted to protect neurons in the future.